Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results
Objectives To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa). Methods We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical...
Saved in:
| Published in: | European radiology Vol. 26; no. 8; pp. 2502 - 2509 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.08.2016
Springer Nature B.V |
| Subjects: | |
| ISSN: | 0938-7994, 1432-1084, 1432-1084 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Objectives
To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa).
Methods
We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox’s proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens ≥0.2 ng/ml). Kaplan-Meier survival curves were analyzed.
Results
The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12–36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (
p
< 0.05), except seminal vesicle invasion (
p
= 0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (
p
< 0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS ≥4 (84.7–85.5 %) than for PI-RADS <4 (100 %;
p
< 0.05).
Conclusion
As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa.
Key Points
•
No subject with PI-RADS <4 had BCR after RP
•
PI-RADSv2 was the only predictor of BCR in multivariate analysis
•
Two-year, BCR-free survival following RP was lower for PI-RADS≥4 than for PI-RADS<4
•
Inter-rater agreement was good for PI-RADS ≥4 or not |
|---|---|
| AbstractList | To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa).
We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox's proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens ≥0.2 ng/ml). Kaplan-Meier survival curves were analyzed.
The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12-36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (p < 0.05), except seminal vesicle invasion (p = 0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (p < 0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS ≥4 (84.7-85.5 %) than for PI-RADS <4 (100 %; p < 0.05).
As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa.
• No subject with PI-RADS <4 had BCR after RP • PI-RADSv2 was the only predictor of BCR in multivariate analysis • Two-year, BCR-free survival following RP was lower for PI-RADS≥4 than for PI-RADS<4 • Inter-rater agreement was good for PI-RADS ≥4 or not. Objectives To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa). Methods We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox’s proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens ≥0.2 ng/ml). Kaplan-Meier survival curves were analyzed. Results The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12–36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR ( p < 0.05), except seminal vesicle invasion ( p = 0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis ( p < 0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS ≥4 (84.7–85.5 %) than for PI-RADS <4 (100 %; p < 0.05). Conclusion As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa. Key Points • No subject with PI-RADS <4 had BCR after RP • PI-RADSv2 was the only predictor of BCR in multivariate analysis • Two-year, BCR-free survival following RP was lower for PI-RADS≥4 than for PI-RADS<4 • Inter-rater agreement was good for PI-RADS ≥4 or not To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa).OBJECTIVESTo determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa).We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox's proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens ≥0.2 ng/ml). Kaplan-Meier survival curves were analyzed.METHODSWe included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox's proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens ≥0.2 ng/ml). Kaplan-Meier survival curves were analyzed.The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12-36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (p < 0.05), except seminal vesicle invasion (p = 0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (p < 0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS ≥4 (84.7-85.5 %) than for PI-RADS <4 (100 %; p < 0.05).RESULTSThe rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12-36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (p < 0.05), except seminal vesicle invasion (p = 0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (p < 0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS ≥4 (84.7-85.5 %) than for PI-RADS <4 (100 %; p < 0.05).As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa.CONCLUSIONAs a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa.• No subject with PI-RADS <4 had BCR after RP • PI-RADSv2 was the only predictor of BCR in multivariate analysis • Two-year, BCR-free survival following RP was lower for PI-RADS≥4 than for PI-RADS<4 • Inter-rater agreement was good for PI-RADS ≥4 or not.KEY POINTS• No subject with PI-RADS <4 had BCR after RP • PI-RADSv2 was the only predictor of BCR in multivariate analysis • Two-year, BCR-free survival following RP was lower for PI-RADS≥4 than for PI-RADS<4 • Inter-rater agreement was good for PI-RADS ≥4 or not. Objectives To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa). Methods We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox's proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens [greater than or equal to]0.2 ng/ml). Kaplan-Meier survival curves were analyzed. Results The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12-36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (p<0.05), except seminal vesicle invasion (p=0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (p<0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS [greater than or equal to]4 (84.7-85.5 %) than for PI-RADS <4 (100 %; p<0.05). Conclusion As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa. Key Points * No subject with PI-RADS <4 had BCR after RP * PI-RADSv2 was the only predictor of BCR in multivariate analysis * Two-year, BCR-free survival following RP was lower for PI-RADS[greater than or equal to]4 than for PI-RADS<4 * Inter-rater agreement was good for PI-RADS [greater than or equal to]4 or not To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical prostatectomy for prostate cancer (PCa). We included 158 patients with PCa who underwent magnetic resonance imaging (MRI) and radical prostatectomy (RP). Clinical (prostate-specific antigen, greatest percentage of core, and percentage of positive core number), PI-RADSv2 score on MRI, and surgical parameters (Gleason score, extracapsular extension, seminal vesicle invasion, and tumour volume) were investigated. Univariate and multivariate analyses using Cox's proportional hazards model were performed to assess parameters predictive of BCR (two consecutive prostate specific antigens greater than or equal to 0.2 ng/ml). Kaplan-Meier survival curves were analyzed. The rate of BCR was 13.3 % (21/158) after surgery (median follow-up, 25 months; range, 12-36). No subject with a PI-RADS score <4 had BCR. In univariate analysis, all parameters were significant for BCR (p<0.05), except seminal vesicle invasion (p=0.254). Meanwhile, PI-RADS score was the only independent parameter for BCR in multivariate analysis (p<0.05). Two-year, BCR-free survival post-RP was significantly lower for PI-RADS greater than or equal to 4 (84.7-85.5 %) than for PI-RADS <4 (100 %; p<0.05). As a preoperative imaging tool, PI-RADSv2 may be useful to predict BCR after radical prostatectomy for PCa. times No subject with PI-RADS <4 had BCR after RP times PI-RADSv2 was the only predictor of BCR in multivariate analysis times Two-year, BCR-free survival following RP was lower for PI-RADS greater than or equal to 4 than for PI-RADS<4 times Inter-rater agreement was good for PI-RADS greater than or equal to 4 or not |
| Author | Cho, Nam Hoon Jung, Dae Chul Hong, Sung Joon Oh, Young Taik Park, Sung Yoon Choi, Young Deuk Rha, Koon Ho |
| Author_xml | – sequence: 1 givenname: Sung Yoon surname: Park fullname: Park, Sung Yoon organization: Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine – sequence: 2 givenname: Young Taik surname: Oh fullname: Oh, Young Taik email: oytaik@yuhs.ac organization: Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine, Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine – sequence: 3 givenname: Dae Chul surname: Jung fullname: Jung, Dae Chul organization: Department of Radiology and Research Institute of Radiological Science, Yonsei University College of Medicine – sequence: 4 givenname: Nam Hoon surname: Cho fullname: Cho, Nam Hoon organization: Department of Pathology, Yonsei University College of Medicine – sequence: 5 givenname: Young Deuk surname: Choi fullname: Choi, Young Deuk organization: Department of Urology, Yonsei University College of Medicine – sequence: 6 givenname: Koon Ho surname: Rha fullname: Rha, Koon Ho organization: Department of Urology, Yonsei University College of Medicine – sequence: 7 givenname: Sung Joon surname: Hong fullname: Hong, Sung Joon organization: Department of Urology, Yonsei University College of Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26560721$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtrFjEYhYNU7NfqD3AjATduUt9cZpJxV-qlhUKLl3XIZN6xKXOpSaZS8Meb6VeLFCySRSB5zsmbc_bIzjRPSMhLDgccQL9NAFICA14xBVqz6gnZcCUF42DUDtlAIw3TTaN2yV5KlwDQcKWfkV1RVzVowTfk13nELvgc5onOPW3D7C9wDN4NNKJfYsTJI3V9xkij624vruKcssvo8zze0J8hX9DzE_b58P0Xeo0xrVaChumeo94Vk5jelcOQw611WoacnpOnvRsSvrjb98m3jx--Hh2z07NPJ0eHp8wrZTLzqFtduwobo0G3Td0L14KsFTaqlVxVvS9LKuMahcbwDkXfd1pIjz24ysl98mbrWyb6sWDKdgzJ4zC4CeclWW5UrThvNP8PFLgSSnFd0NcP0Mt5iVP5yEqVZoyQVaFe3VFLO2Jnr2IYXbyxfyooAN8CvsSVIvb3CAe71my3NdtSs11rtqupfqDxoSRdks_RheFRpdgqU3ll-o7xr6H_KfoNeXK7wg |
| CitedBy_id | crossref_primary_10_1186_s40644_025_00907_8 crossref_primary_10_1002_pros_24302 crossref_primary_10_1002_pros_24303 crossref_primary_10_1136_bmjopen_2020_047664 crossref_primary_10_3390_diagnostics12020289 crossref_primary_10_1007_s00330_019_06114_x crossref_primary_10_1016_j_urology_2023_03_014 crossref_primary_10_2217_fon_2016_0169 crossref_primary_10_1007_s00330_017_4800_5 crossref_primary_10_1002_jmri_25539 crossref_primary_10_1007_s00330_020_07569_z crossref_primary_10_3390_cancers14071613 crossref_primary_10_1002_jmri_25856 crossref_primary_10_1038_s41391_019_0164_z crossref_primary_10_3348_kjr_2018_19_2_193 crossref_primary_10_3389_fonc_2019_00572 crossref_primary_10_1007_s00330_019_06092_0 crossref_primary_10_1016_j_mri_2022_08_008 crossref_primary_10_1002_jmri_26243 crossref_primary_10_3390_jcm9123841 crossref_primary_10_1016_j_jacr_2017_04_012 crossref_primary_10_1259_bjr_20220663 crossref_primary_10_1016_j_ucl_2017_07_012 crossref_primary_10_1007_s00120_017_0515_0 crossref_primary_10_1111_bju_13562 crossref_primary_10_3390_app10113854 crossref_primary_10_2217_fon_2016_0178 crossref_primary_10_1007_s00259_017_3725_1 crossref_primary_10_3389_fonc_2018_00630 crossref_primary_10_1007_s00345_016_1960_x crossref_primary_10_14366_usg_22202 crossref_primary_10_1371_journal_pone_0283830 crossref_primary_10_1007_s00330_017_5031_5 crossref_primary_10_3389_fonc_2022_841801 crossref_primary_10_1016_j_euo_2020_11_008 crossref_primary_10_1016_j_clinimag_2025_110579 crossref_primary_10_1111_iju_14633 crossref_primary_10_3389_fonc_2020_01547 crossref_primary_10_3348_kjr_2018_0613 |
| Cites_doi | 10.1001/jama.294.4.433 10.1016/j.eururo.2011.02.026 10.1148/radiol.13120641 10.1007/s00330-011-2377-y 10.1111/j.1464-410X.2009.08406.x 10.1016/S0022-5347(05)63946-8 10.1046/j.1464-410X.2002.02669.x 10.1016/j.juro.2010.07.037 10.2214/AJR.13.11381 10.1016/j.ijrobp.2012.01.009 10.1148/radiol.13130801 10.1097/RLI.0000000000000008 10.1148/radiol.11102066 10.1016/j.eururo.2008.11.005 10.1016/j.eururo.2013.03.053 10.1001/jama.281.17.1591 10.1001/archinternmed.2010.262 10.1148/radiol.13122233 10.1016/j.juro.2010.03.039 10.1200/JCO.2011.35.1924 10.1148/radiol.2492071681 10.2307/2529310 10.1093/jnci/djj190 10.1016/j.eururo.2013.11.002 10.1111/bju.12329 10.1148/radiol.11110457 10.1007/s00330-010-1999-9 10.1016/j.eururo.2013.05.045 10.1016/j.eururo.2009.03.012 10.1007/s00330-013-3017-5 10.1148/radiol.15141412:141412 10.1016/j.eururo.2014.10.033 10.1148/radiol.14140184:140184 |
| ContentType | Journal Article |
| Copyright | European Society of Radiology 2015 European Society of Radiology 2016 |
| Copyright_xml | – notice: European Society of Radiology 2015 – notice: European Society of Radiology 2016 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QO 7RV 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ P5Z P62 P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 |
| DOI | 10.1007/s00330-015-4077-5 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Biotechnology Research Abstracts Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Technology Collection Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic ProQuest Central Student Engineering Research Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-1084 |
| EndPage | 2509 |
| ExternalDocumentID | 4103967431 26560721 10_1007_s00330_015_4077_5 |
| Genre | Journal Article |
| GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 04C 06C 06D 0R~ 0VY 1N0 1SB 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5VS 67Z 6NX 6PF 7RV 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBXY ACDTI ACGFO ACGFS ACHSB ACHVE ACHXU ACIHN ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACUDM ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADOJX ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFEXP AFJLC AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGVAE AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS ECF ECT EIHBH EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I-F I09 IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P62 P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 Z7R Z7U Z7X Z7Y Z7Z Z82 Z83 Z85 Z87 Z88 Z8M Z8O Z8R Z8S Z8T Z8V Z8W Z8Z Z91 Z92 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC ADHKG ADKFA AEZWR AFDZB AFFHD AFHIU AFOHR AGQPQ AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7QO 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS 7X8 |
| ID | FETCH-LOGICAL-c448t-ce7b76a5e98707b96f2ab0364e94b3145fcfcf348a94e881de2ffd723cef0a5a3 |
| IEDL.DBID | 7RV |
| ISICitedReferencesCount | 49 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000379192500011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0938-7994 1432-1084 |
| IngestDate | Tue Oct 07 09:21:09 EDT 2025 Sun Nov 09 12:43:02 EST 2025 Tue Dec 02 15:58:07 EST 2025 Wed Feb 19 02:31:23 EST 2025 Tue Nov 18 20:12:33 EST 2025 Sat Nov 29 04:36:58 EST 2025 Fri Feb 21 02:32:51 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | Radical prostatectomy MRI Biochemical recurrence Prostate cancer PI-RADS |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c448t-ce7b76a5e98707b96f2ab0364e94b3145fcfcf348a94e881de2ffd723cef0a5a3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://link.springer.com/article/10.1007%2Fs00330-015-4077-5 |
| PMID | 26560721 |
| PQID | 1800338235 |
| PQPubID | 54162 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_1846411971 proquest_miscellaneous_1801424417 proquest_journals_1800338235 pubmed_primary_26560721 crossref_primary_10_1007_s00330_015_4077_5 crossref_citationtrail_10_1007_s00330_015_4077_5 springer_journals_10_1007_s00330_015_4077_5 |
| PublicationCentury | 2000 |
| PublicationDate | 20160800 2016-8-00 2016-Aug 20160801 |
| PublicationDateYYYYMMDD | 2016-08-01 |
| PublicationDate_xml | – month: 8 year: 2016 text: 20160800 |
| PublicationDecade | 2010 |
| PublicationPlace | Berlin/Heidelberg |
| PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Heidelberg |
| PublicationTitle | European radiology |
| PublicationTitleAbbrev | Eur Radiol |
| PublicationTitleAlternate | Eur Radiol |
| PublicationYear | 2016 |
| Publisher | Springer Berlin Heidelberg Springer Nature B.V |
| Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
| References | Touijer, Mazzola, Sjoberg, Scardino, Eastham (CR33) 2014; 65 Arumainayagam, Ahmed, Moore (CR27) 2013; 268 Park, Kim, Park, Lee, Lee (CR9) 2011; 21 Sasaki, Yamada, Watanabe (CR14) 2008; 249 Stephenson, Scardino, Eastham (CR1) 2006; 98 Briganti, Blute, Eastham (CR35) 2009; 55 Hattori, Kosaka, Mizuno (CR25) 2014; 113 Pound, Partin, Eisenberger, Chan, Pearson, Walsh (CR4) 1999; 281 Hamoen, de Rooij, Witjes, Barentsz, Rovers (CR17) 2014 Vargas, Akin, Franiel (CR23) 2011; 259 Kim, Kim, Kim, Lee, Kim, Choi (CR26) 2014; 271 Vos, Litjens, Kobus (CR24) 2013; 64 Zakian, Hricak, Ishill (CR8) 2010; 184 Park, Kim, Park, Park, Lee, Cho (CR10) 2014; 202 Hoeks, Somford, van Oort (CR18) 2014; 49 Roethke, Kuru, Schultze (CR19) 2014; 24 Landis, Koch (CR22) 1977; 33 Egevad, Granfors, Karlberg, Bergh, Stattin (CR28) 2002; 89 Han, Partin, Zahurak, Piantadosi, Epstein, Walsh (CR2) 2003; 169 Barentsz, Richenberg, Clements (CR15) 2012; 22 Fuchsjager, Shukla-Dave, Hricak (CR7) 2009; 104 Westphalen, Koff, Coakley (CR11) 2011; 261 Rosenkrantz, Kim, Lim (CR16) 2013; 269 Riaz, Afaq, Akin (CR12) 2012; 84 Uchio, Aslan, Wells, Calderone, Concato (CR6) 2010; 170 Buyyounouski, Pickles, Kestin, Allison, Williams (CR32) 2012; 30 Heidenreich, Bastian, Bellmunt (CR3) 2014; 65 von Bodman, Godoy, Chade (CR34) 2010; 184 CR21 Kivrak, Paksoy, Erol, Koplay, Ozbek, Kara (CR13) 2013; 19 Boorjian, Thompson, Tollefson (CR5) 2011; 59 Kayat Bittencourt, Litjens, Hulsbergen-van de Kaa, Turkbey, Gasparetto, Barentsz (CR30) 2015 Walz, Chun, Klein (CR29) 2009; 55 Freedland, Humphreys, Mangold (CR31) 2005; 294 Renard-Penna, Mozer, Cornud (CR20) 2015 JY Kim (4077_CR26) 2014; 271 AS Kivrak (4077_CR13) 2013; 19 J Walz (4077_CR29) 2009; 55 L Kayat Bittencourt (4077_CR30) 2015 KA Touijer (4077_CR33) 2014; 65 R Renard-Penna (4077_CR20) 2015 HA Vargas (4077_CR23) 2011; 259 MH Fuchsjager (4077_CR7) 2009; 104 SY Park (4077_CR9) 2011; 21 MC Roethke (4077_CR19) 2014; 24 A Heidenreich (4077_CR3) 2014; 65 AJ Stephenson (4077_CR1) 2006; 98 JJ Park (4077_CR10) 2014; 202 AB Rosenkrantz (4077_CR16) 2013; 269 EK Vos (4077_CR24) 2013; 64 M Han (4077_CR2) 2003; 169 A Briganti (4077_CR35) 2009; 55 CR Pound (4077_CR4) 1999; 281 EM Uchio (4077_CR6) 2010; 170 CM Hoeks (4077_CR18) 2014; 49 N Riaz (4077_CR12) 2012; 84 S Hattori (4077_CR25) 2014; 113 JO Barentsz (4077_CR15) 2012; 22 L Egevad (4077_CR28) 2002; 89 AC Westphalen (4077_CR11) 2011; 261 MK Buyyounouski (4077_CR32) 2012; 30 C Bodman von (4077_CR34) 2010; 184 SJ Freedland (4077_CR31) 2005; 294 SA Boorjian (4077_CR5) 2011; 59 EH Hamoen (4077_CR17) 2014 N Arumainayagam (4077_CR27) 2013; 268 4077_CR21 M Sasaki (4077_CR14) 2008; 249 KL Zakian (4077_CR8) 2010; 184 JR Landis (4077_CR22) 1977; 33 28854465 - Aktuelle Urol. 2017 Sep;48(5):414-415 |
| References_xml | – volume: 294 start-page: 433 year: 2005 end-page: 439 ident: CR31 article-title: Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy publication-title: JAMA doi: 10.1001/jama.294.4.433 – volume: 59 start-page: 893 year: 2011 end-page: 899 ident: CR5 article-title: Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence publication-title: Eur Urol doi: 10.1016/j.eururo.2011.02.026 – volume: 268 start-page: 761 year: 2013 end-page: 769 ident: CR27 article-title: Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard publication-title: Radiology doi: 10.1148/radiol.13120641 – volume: 22 start-page: 746 year: 2012 end-page: 757 ident: CR15 article-title: ESUR prostate MR guidelines 2012 publication-title: Eur Radiol doi: 10.1007/s00330-011-2377-y – volume: 104 start-page: 315 year: 2009 end-page: 320 ident: CR7 article-title: Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy publication-title: BJU Int doi: 10.1111/j.1464-410X.2009.08406.x – volume: 169 start-page: 517 year: 2003 end-page: 523 ident: CR2 article-title: Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer publication-title: J Urol doi: 10.1016/S0022-5347(05)63946-8 – year: 2014 ident: CR17 article-title: Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis publication-title: Eur Urol – volume: 89 start-page: 538 year: 2002 end-page: 542 ident: CR28 article-title: Prognostic value of the Gleason score in prostate cancer publication-title: BJU Int doi: 10.1046/j.1464-410X.2002.02669.x – volume: 184 start-page: 2320 year: 2010 end-page: 2327 ident: CR8 article-title: An exploratory study of endorectal magnetic resonance imaging and spectroscopy of the prostate as preoperative predictive biomarkers of biochemical relapse after radical prostatectomy publication-title: J Urol doi: 10.1016/j.juro.2010.07.037 – volume: 202 start-page: W459 year: 2014 end-page: W465 ident: CR10 article-title: Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.13.11381 – year: 2015 ident: CR30 article-title: Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging publication-title: Radiology – volume: 84 start-page: 707 year: 2012 end-page: 711 ident: CR12 article-title: Pretreatment endorectal coil magnetic resonance imaging findings predict biochemical tumor control in prostate cancer patients treated with combination brachytherapy and external-beam radiotherapy publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.01.009 – volume: 271 start-page: 435 year: 2014 end-page: 444 ident: CR26 article-title: Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detection publication-title: Radiology doi: 10.1148/radiol.13130801 – volume: 49 start-page: 165 year: 2014 end-page: 172 ident: CR18 article-title: Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study publication-title: Investig Radiol doi: 10.1097/RLI.0000000000000008 – volume: 259 start-page: 775 year: 2011 end-page: 784 ident: CR23 article-title: Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness publication-title: Radiology doi: 10.1148/radiol.11102066 – volume: 55 start-page: 412 year: 2009 end-page: 419 ident: CR29 article-title: Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy publication-title: Eur Urol doi: 10.1016/j.eururo.2008.11.005 – volume: 65 start-page: 20 year: 2014 end-page: 25 ident: CR33 article-title: Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy publication-title: Eur Urol doi: 10.1016/j.eururo.2013.03.053 – volume: 281 start-page: 1591 year: 1999 end-page: 1597 ident: CR4 article-title: Natural history of progression after PSA elevation following radical prostatectomy publication-title: JAMA doi: 10.1001/jama.281.17.1591 – volume: 170 start-page: 1390 year: 2010 end-page: 1395 ident: CR6 article-title: Impact of biochemical recurrence in prostate cancer among US veterans publication-title: Arch Intern Med doi: 10.1001/archinternmed.2010.262 – volume: 269 start-page: 482 year: 2013 end-page: 492 ident: CR16 article-title: Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales publication-title: Radiology doi: 10.1148/radiol.13122233 – volume: 184 start-page: 143 year: 2010 end-page: 148 ident: CR34 article-title: Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy publication-title: J Urol doi: 10.1016/j.juro.2010.03.039 – volume: 30 start-page: 1857 year: 2012 end-page: 1863 ident: CR32 article-title: Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.1924 – ident: CR21 – volume: 249 start-page: 624 year: 2008 end-page: 630 ident: CR14 article-title: Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multi-institutional comparison study publication-title: Radiology doi: 10.1148/radiol.2492071681 – volume: 33 start-page: 159 year: 1977 end-page: 174 ident: CR22 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics doi: 10.2307/2529310 – volume: 98 start-page: 715 year: 2006 end-page: 717 ident: CR1 article-title: Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj190 – volume: 65 start-page: 467 year: 2014 end-page: 479 ident: CR3 article-title: EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer publication-title: Eur Urol doi: 10.1016/j.eururo.2013.11.002 – year: 2015 ident: CR20 article-title: Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy publication-title: Radiology – volume: 113 start-page: 741 year: 2014 end-page: 747 ident: CR25 article-title: Prognostic value of preoperative multiparametric magnetic resonance imaging (MRI) for predicting biochemical recurrence after radical prostatectomy publication-title: BJU Int doi: 10.1111/bju.12329 – volume: 261 start-page: 477 year: 2011 end-page: 486 ident: CR11 article-title: Prostate cancer: prediction of biochemical failure after external-beam radiation therapy--Kattan nomogram and endorectal MR imaging estimation of tumor volume publication-title: Radiology doi: 10.1148/radiol.11110457 – volume: 21 start-page: 1111 year: 2011 end-page: 1118 ident: CR9 article-title: Prediction of biochemical recurrence following radical prostatectomy in men with prostate cancer by diffusion-weighted magnetic resonance imaging: initial results publication-title: Eur Radiol doi: 10.1007/s00330-010-1999-9 – volume: 64 start-page: 448 year: 2013 end-page: 455 ident: CR24 article-title: Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T publication-title: Eur Urol doi: 10.1016/j.eururo.2013.05.045 – volume: 55 start-page: 1251 year: 2009 end-page: 1265 ident: CR35 article-title: Pelvic lymph node dissection in prostate cancer publication-title: Eur Urol doi: 10.1016/j.eururo.2009.03.012 – volume: 19 start-page: 433 year: 2013 end-page: 437 ident: CR13 article-title: Comparison of apparent diffusion coefficient values among different MRI platforms: a multicenter phantom study publication-title: Diagn Interv Radiol – volume: 24 start-page: 344 year: 2014 end-page: 352 ident: CR19 article-title: Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla publication-title: Eur Radiol doi: 10.1007/s00330-013-3017-5 – volume: 55 start-page: 1251 year: 2009 ident: 4077_CR35 publication-title: Eur Urol doi: 10.1016/j.eururo.2009.03.012 – volume: 184 start-page: 2320 year: 2010 ident: 4077_CR8 publication-title: J Urol doi: 10.1016/j.juro.2010.07.037 – volume: 59 start-page: 893 year: 2011 ident: 4077_CR5 publication-title: Eur Urol doi: 10.1016/j.eururo.2011.02.026 – volume: 113 start-page: 741 year: 2014 ident: 4077_CR25 publication-title: BJU Int doi: 10.1111/bju.12329 – volume: 269 start-page: 482 year: 2013 ident: 4077_CR16 publication-title: Radiology doi: 10.1148/radiol.13122233 – year: 2015 ident: 4077_CR30 publication-title: Radiology doi: 10.1148/radiol.15141412:141412 – volume: 98 start-page: 715 year: 2006 ident: 4077_CR1 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj190 – volume: 268 start-page: 761 year: 2013 ident: 4077_CR27 publication-title: Radiology doi: 10.1148/radiol.13120641 – volume: 30 start-page: 1857 year: 2012 ident: 4077_CR32 publication-title: J Clin Oncol doi: 10.1200/JCO.2011.35.1924 – volume: 24 start-page: 344 year: 2014 ident: 4077_CR19 publication-title: Eur Radiol doi: 10.1007/s00330-013-3017-5 – volume: 22 start-page: 746 year: 2012 ident: 4077_CR15 publication-title: Eur Radiol doi: 10.1007/s00330-011-2377-y – volume: 281 start-page: 1591 year: 1999 ident: 4077_CR4 publication-title: JAMA doi: 10.1001/jama.281.17.1591 – volume: 49 start-page: 165 year: 2014 ident: 4077_CR18 publication-title: Investig Radiol doi: 10.1097/RLI.0000000000000008 – volume: 261 start-page: 477 year: 2011 ident: 4077_CR11 publication-title: Radiology doi: 10.1148/radiol.11110457 – volume: 184 start-page: 143 year: 2010 ident: 4077_CR34 publication-title: J Urol doi: 10.1016/j.juro.2010.03.039 – year: 2014 ident: 4077_CR17 publication-title: Eur Urol doi: 10.1016/j.eururo.2014.10.033 – volume: 55 start-page: 412 year: 2009 ident: 4077_CR29 publication-title: Eur Urol doi: 10.1016/j.eururo.2008.11.005 – volume: 104 start-page: 315 year: 2009 ident: 4077_CR7 publication-title: BJU Int doi: 10.1111/j.1464-410X.2009.08406.x – volume: 21 start-page: 1111 year: 2011 ident: 4077_CR9 publication-title: Eur Radiol doi: 10.1007/s00330-010-1999-9 – volume: 19 start-page: 433 year: 2013 ident: 4077_CR13 publication-title: Diagn Interv Radiol – volume: 64 start-page: 448 year: 2013 ident: 4077_CR24 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.05.045 – volume: 169 start-page: 517 year: 2003 ident: 4077_CR2 publication-title: J Urol doi: 10.1016/S0022-5347(05)63946-8 – year: 2015 ident: 4077_CR20 publication-title: Radiology doi: 10.1148/radiol.14140184:140184 – ident: 4077_CR21 – volume: 170 start-page: 1390 year: 2010 ident: 4077_CR6 publication-title: Arch Intern Med doi: 10.1001/archinternmed.2010.262 – volume: 84 start-page: 707 year: 2012 ident: 4077_CR12 publication-title: Int J Radiat Oncol Biol Phys doi: 10.1016/j.ijrobp.2012.01.009 – volume: 271 start-page: 435 year: 2014 ident: 4077_CR26 publication-title: Radiology doi: 10.1148/radiol.13130801 – volume: 65 start-page: 20 year: 2014 ident: 4077_CR33 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.03.053 – volume: 249 start-page: 624 year: 2008 ident: 4077_CR14 publication-title: Radiology doi: 10.1148/radiol.2492071681 – volume: 202 start-page: W459 year: 2014 ident: 4077_CR10 publication-title: AJR Am J Roentgenol doi: 10.2214/AJR.13.11381 – volume: 33 start-page: 159 year: 1977 ident: 4077_CR22 publication-title: Biometrics doi: 10.2307/2529310 – volume: 259 start-page: 775 year: 2011 ident: 4077_CR23 publication-title: Radiology doi: 10.1148/radiol.11102066 – volume: 89 start-page: 538 year: 2002 ident: 4077_CR28 publication-title: BJU Int doi: 10.1046/j.1464-410X.2002.02669.x – volume: 65 start-page: 467 year: 2014 ident: 4077_CR3 publication-title: Eur Urol doi: 10.1016/j.eururo.2013.11.002 – volume: 294 start-page: 433 year: 2005 ident: 4077_CR31 publication-title: JAMA doi: 10.1001/jama.294.4.433 – reference: 28854465 - Aktuelle Urol. 2017 Sep;48(5):414-415 |
| SSID | ssj0009147 |
| Score | 2.404694 |
| Snippet | Objectives
To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical... To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical... Objectives To determine whether the Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) helps predict biochemical recurrence (BCR) after radical... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2502 |
| SubjectTerms | Aged Aged, 80 and over Antigens Biopsy Diagnostic Radiology Humans Imaging Internal Medicine Interventional Radiology Kaplan-Meier Estimate Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Medical schools Medicine Medicine & Public Health Middle Aged Multivariate Analysis Neoplasm Recurrence, Local - metabolism Neoplasm Recurrence, Local - pathology Neuroradiology Predictive Value of Tests Proportional Hazards Models Prostate cancer Prostate-Specific Antigen - analysis Prostatectomy - methods Prostatic Neoplasms - diagnostic imaging Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Radiology Retrospective Studies Ultrasound University colleges Urogenital |
| SummonAdditionalLinks | – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qK9IXrV_1tJUt-KQELsl--laspQUtR6vSt7C72cBBzZXkriD4xzuz-ajSWlDyEpLJMtnZ2Z3Z384MwBsZSpwQ0VPlmUMHpZSoUtJXiTNTm5bScOuipD-pkxN9fm5mfRx3O5x2HyDJOFOPwW5UdowOUQn0eZRKxD3YwNVOkzaenn27zrSbxqpi6KnrRBnDByjztib-XIxuWJg30NG46Bw--i92t-Bhb2Oy_W5QPIa1UD-BB597FP0p_Jw1dE8iYYuKuTlVzYppA1hD2-8xAJDF6uGssRHIYZcUHWIJcVh8_8Fo95bNjpPT_YMzdtVtubGMzeuRjnkaTk37Hh_OcRahptvVxbJ9Bl8PP375cJT0VRgSj67bMvFBOSWtCAZVWzkjq8w6Qi-D4S5Puag8XjnX1vCg0fwNWVWVKst9qKZW2Pw5rNeLOrwAZpTj3Ls8y4Xn0mda28oINDhLKUIe0glMB3EUvk9RTpUyLooxuXLs1QJ7taBeLcQE3o6fXHb5Oe4i3hlkXPSq2hapJjKNPE1gb3yNSkbIia3DYhVpYkRgqu6i4ZITKIu_sd2Nn5GjjFIcoa89gXfDYPmNgb-x-_KfqF_BJhpzsjucuAPry2YVduG-v1rO2-Z11JFfoGsKkA priority: 102 providerName: Springer Nature |
| Title | Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results |
| URI | https://link.springer.com/article/10.1007/s00330-015-4077-5 https://www.ncbi.nlm.nih.gov/pubmed/26560721 https://www.proquest.com/docview/1800338235 https://www.proquest.com/docview/1801424417 https://www.proquest.com/docview/1846411971 |
| Volume | 26 |
| WOSCitedRecordID | wos000379192500011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1432-1084 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: P5Z dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Sciences customDbUrl: eissn: 1432-1084 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: M7P dateStart: 19970101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1432-1084 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: 7X7 dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1432-1084 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: 7RV dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest customDbUrl: eissn: 1432-1084 dateEnd: 20171231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: BENPR dateStart: 19970101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: Springer Journals customDbUrl: eissn: 1432-1084 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009147 issn: 0938-7994 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEA96J-KL3x-r5xLBJ6W4bfPpi5x6h4IuZU-PxZeSpCksnO3a7h4I_vHOpB-nHO6LFEJp0zLtzCQz80tmCHkufAEDIniqLLHgoBQCVEq4MrJ6ZuJCaGZs4PQnOZ-r5VJnfcCt7ZdVDmNiGKiL2mGM_FWssOyYSlL-Zv0jwqpRiK72JTSukv0Y526QZ7k4vUi6G4cCY-C0q0hqzQZUcxaSiIInD440Bw9Kyoj_PS9dMjYvAaVh_jm-9b-U3yY3e8uTHnaicodc8dVdcv1zj63fI7-yBs-RUbQuqV1hLa2QTIA2GJQP2wJpqClOGxPgHbrGPSMGcYj6-0-KMV2afYwWh-9P6HkXiKMJXVVjP-pQyJr2NVxcwdiCr263Z5v2Pvl6fPTl3Yeor80QOXDoNpHz0kphuNeg8NJqUSbGIqbpNbNpzHjp4EiZMpp5BUaxT8qykEnqfDkz3KQPyF5VV_4RoVpaxpxN4Qc5JlyilCk1BzO0ENynPp6Q2cCZ3PWJy7F-xlk-plwOzMyBmTkyM-cT8mJ8ZN1l7djV-WDgW94rcJtfMG1Cno23QfUQTzGVr7ehT9gnGMtdfZhgCNXCZzzsRGmkKMHER-CBT8jLQbb-IOBf5D7eTe4TcgNsOtGtUTwge5tm65-Sa-58s2qbadAPbJcytGpK9t8ezbPFFBe9ZtBm_Bu0i5PT3yekG7o |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQcCF92OhgJHgAopIHMeOKyFUUaquul2toEh7C7bjSCuVZEl2iyrxm_iNnXE2Kahibz2gXKLYiez483jG33iGkFfC5SAQwVLlzICBkguYUsIWgVGhjnKhuDZ-pEdyPE6nUzXZIL-7szDoVtnJRC-o88riHvm7KMW0YymLkw_zHwFmjUJ2tUuh0cLiwJ3-BJOteT_chfF9zdjep6OP-8Eqq0BgwRRZBNZJI4VOHFjboTRKFEwbZOOc4iaOeFJYuGKeasVdCuqcY0WRSxZbV4Q60TF89wq5CnJcoguZnMrzIL-RT2gWKhAiUinesaihD1oax-gCloDFJmWQ_L0OXlBuLxCzfr3bu_2__ak75NZKs6Y77VS4SzZceY9cP1z5DtwnvyY13iMQaVVQM8NcYT5YAq2RdPDHHqnPmU5r7ekrOsczMRp5lur7KcU9azoZBp93dr_Qk3ajkTI6K_t61OIkqptteDgD2YmfbpbHi-YB-XopfX9INsuqdI8JVdJwbk0MA2K5sCxNdaESULNzkbjYRQMSdkjI7CowO-YHOc76kNIePBmAJ0PwZMmAvOlfmbdRSdZV3upwkq0EVJOdg2RAXvbFIFqQL9Klq5a-jj8HGcl1dbjgSEVDNx610O1bxDCwk2RQ8rbD8h8N-Fdzn6xv7gtyY__ocJSNhuODp-Qm6K-i9cfcIpuLeumekWv2ZDFr6ud-blLy7bIhfgYudXQ_ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELZKQRUX3tCFAkaCCyhq4jh2jIRQxbJi1bKKeEhVL8FxHGmlNlmS3aJK_DJ-HTPOo6CKvfWAcoliJ7Ljz-MZf-MZQp4Lm4NABEuVswwMlFzAlBKm8DLl6yAXiuvMjfSBnM3iw0OVbJBf_VkYdKvsZaIT1HllcI98N4gx7VjMwmi36NwikvHk7eK7hxmkkGnt02m0ENm3Zz_AfGveTMcw1i8Ym7z_8u6D12UY8AyYJUvPWJlJoSMLlrcvMyUKpjNk5qziWRjwqDBwhTzWitsYVDvLiiKXLDS28HWkQ_juFXJVgo2Jhl8SHZ0H_A1ccjNfgUCRSvGeUfVdANMwRHewCKw3Kb3o7zXxgqJ7gaR1a9_k5v_8126RG53GTffaKXKbbNjyDtn62PkU3CU_kxrvEaC0Kmg2xxxiLogCrZGMcMchqculTmvtaC26wLMyGvmX6uSM4l42Tabep73xZ3rabkBSRuflUI8anFx18xoezkGm4qeb1fGyuUe-Xkrf75PNsirtNqFKZpybLITBMVwYFse6UBGo37mIbGiDEfF7VKSmC9iOeUOO0yHUtANSCkBKEUhpNCIvh1cWbbSSdZV3esykneBq0nPAjMizoRhEDvJIurTVytVx5yMDua4OFxwpaujGgxbGQ4sYBnySDEpe9bj-owH_au7D9c19SrYA2enBdLb_iFwHtVa0bpo7ZHNZr-xjcs2cLudN_cRNU0q-XTbCfwM1uH0y |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prediction+of+biochemical+recurrence+after+radical+prostatectomy+with+PI-RADS+version+2+in+prostate+cancers%3A+initial+results&rft.jtitle=European+radiology&rft.au=Park%2C+Sung+Yoon&rft.au=Oh%2C+Young+Taik&rft.au=Jung%2C+Dae+Chul&rft.au=Cho%2C+Nam+Hoon&rft.date=2016-08-01&rft.issn=1432-1084&rft.eissn=1432-1084&rft.volume=26&rft.issue=8&rft.spage=2502&rft_id=info:doi/10.1007%2Fs00330-015-4077-5&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0938-7994&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0938-7994&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0938-7994&client=summon |